stockportfolio.pro
Elevance Health, Inc. P/E Ratio 2007–2025
Elevance Health, Inc. (ELV) annual price-to-earnings ratio by fiscal year, computed from SEC filings. Compound growth +0.5%/yr over 18 years.
| Fiscal year | P/E Ratio | Change (YoY) |
|---|---|---|
| FY 2025 | 13.75 | -1.4% |
| FY 2024 | 13.95 | -22.2% |
| FY 2023 | 17.93 | -10.4% |
| FY 2022 | 20.02 | +15.0% |
| FY 2021 | 17.41 | +5.3% |
| FY 2020 | 16.54 | +10.7% |
| FY 2019 | 14.94 | -10.6% |
| FY 2018 | 16.72 | +19.5% |
| FY 2017 | 13.99 | +2.0% |
| FY 2016 | 13.72 | +7.1% |
| FY 2015 | 12.81 | +8.1% |
| FY 2014 | 11.85 | +26.2% |
| FY 2013 | 9.40 | +54.4% |
| FY 2012 | 6.08 | -17.1% |
| FY 2011 | 7.34 | +12.8% |
| FY 2010 | 6.51 | +38.9% |
| FY 2009 | 4.69 | -33.3% |
| FY 2008 | 7.03 | -43.9% |
| FY 2007 | 12.53 | — |
Source: Elevance Health, Inc. SEC filings — fiscal-year-end price ÷ diluted EPS. Refreshed nightly.
See the full picture for Elevance Health, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeElevance Health, Inc. — frequently asked questions
What is Elevance Health, Inc.'s price-to-earnings ratio?
Elevance Health, Inc. (ELV) reported price-to-earnings ratio of 13.75 for fiscal year 2025, per its SEC filings.
How has Elevance Health, Inc.'s price-to-earnings ratio changed over time?
Between fiscal 2007 and 2025, ELV's price-to-earnings ratio grew at roughly 0.5% per year (compound annual rate), from 12.53 to 13.75.
Where does this data come from?
Figures are computed from Elevance Health, Inc.'s official SEC filings (fiscal-year-end price ÷ diluted EPS), refreshed nightly. Not investment advice.